Hepatologist shares which foods and drinks you should restrict, completely avoid or consume to reduce fatty liver risk
The World Health Organisation (WHO) data published on Sciencedirect.com in April 2024 shows the growing burden of liver…
Prevalence of Hepatitis E genotype 3 among liver disease patients in Southwestern Nigeria | Virology Journal
Stanaway JD, Flaxman AD, Naghavi M, Fitzmaurice C, Vos T, Abubakar I, et al. The global burden of…
GLP-1 goliath updates demand for top weight loss drug
Novo Nordisk reported Q3 2025 earnings on November 5, showing continued strong demand for its weight-loss drug Wegovy,…
Liver Drug Approval and Pipeline Data Could Be a Game Changer for Gilead Sciences (GILD)
In recent weeks, Gilead Sciences announced Health Canada’s conditional approval of LYVDELZI (seladelpar) for primary biliary cholangitis, and…
Lab-grown organoid offers a platform to study how liver scarring develops
As chronic liver disease becomes more widespread, researchers at Science Tokyo have developed a lab-grown organoid that replicates…
Nanoparticles offer new hope for treating alcohol-related liver disease
Across the world, more than 1.5 billion people suffer from chronic liver disease. The U.S. Centers for Disease…
Blocking key protein restores healthy lung function and reduces fibrosis in mice
Pulmonary fibrosis is a deadly disease in which the lungs become thickened and scarred, gradually losing their ability…
Study links gut dysbiosis with severe steatosis in MASLD
A new study in eGastroenterology links gut dysbiosis with severe steatosis in metabolic dysfunction–associated steatotic liver disease (MASLD). In a…
Alcohol’s toxic role in rising liver disease epidemic: From cirrhosis to organ failure, how liquor spikes risk
Research has revealed a steep increase in liver disease in recent years. Meanwhile, there is growing evidence of…
Study identifies key molecular and clinical biomarkers for MASLD
Background and aims The causal biomarkers for metabolic dysfunction-associated steatotic liver disease (MASLD) and their clinical value remain…
Genetic study shows dual GIPR/GLP1R action curbs binge alcohol use
New genetic evidence suggests that targeting GIPR and GLP1R could reduce harmful drinking patterns while improving liver and…
Genetic mutation in some East Asians linked to aldehyde storm and increased liver disease risk
Researchers have identified the mechanism by which a common genetic mutation increases liver disease risk. Their findings suggest…